Freenome has appointed Cheng-Ho Jimmy Lin as its CSO. Prior to joining the private sector, Lin led the intramural clinical genomics program at the National Cancer Institute at the National Institutes of Health. At Johns Hopkins and Washington University in St Louis, Lin spearheaded the computational analyses of exome sequencing studies in multiple cancer types. Lin's most recent role was CSO of oncology at Natera, where he drove the development and launch of that firm's blood-based assays for cancer monitoring residual disease detection.
Inscripta has appointed Ron McGrath as its CFO. McGrath has held various leadership and financial roles in the biotechnology and information technology industries. Prior to Inscripta, McGrath served as VP of finance at Illumina. He also served as chief of staff for the company's operations. Before joining Illumina, McGrath held financial leadership roles at Memec and DJ Orthopedics.
Contextual Genomics has appointed Sue Paish as the chair of its board of directors. She will be replacing Chris Wagner, who is stepping down but will remain a director. Paish is currently CEO of the Digital Technology Super Cluster, chair of the board of directors of the Business Council of British Columbia, and a director of CORIX Group. Paish joined Contextual Genomics in 2018 and previously served as president and CEO of LifeLabs Medical Laboratory Services. Prior to LifeLabs, Paish served as CEO of Pharmasave and managing partner of Fasken.
For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.